TABLE 5.
Case # | Original diagnoses | Panelist responses | (%A) | (%AL) | ||||
---|---|---|---|---|---|---|---|---|
TMA | No TMA | TMA | No TMA | 61–80 %AL in 31/37 cases (83.8%) | 81–96 %AL in 20/37 cases (54.1%) | 97–100 %AL in 4/37 cases (10.8%) | ||
1 | TMA (diffuse) | 19 | 4 | 83 | 17 | X | X | — |
2 | TMA (focal) + AMR | 22 | 1 | 96 | 4 | X | X | — |
3 | TMA (acute & chronic) | 23 | 0 | 100 | 0 | X | X | X |
4 | TMA (classical case) | 22 | 1 | 96 | 4 | X | X | — |
5 | TMA (classical case) | 22 | 1 | 96 | 4 | X | X | — |
6 | TMA (early) | 11 | 12 | 48 | 52 | — | — | — |
7 | TMA found on EM only | 8 | 15 | 35 | 65 | X | — | — |
8 | TMA found on EM only | 4 | 19 | 17 | 83 | X | X | — |
9 | TMA (classical case) | 22 | 1 | 96 | 4 | X | X | — |
10 | AMR + TMA | 12 | 11 | 52 | 48 | — | — | — |
11 | TMA (classical case) | 19 | 4 | 83 | 17 | X | X | — |
12 | No TMA (suspicious for AMR) | 7 | 16 | 30 | 70 | X | — | — |
13 | No TMA (TCMR +C4d-neg AMR) | 5 | 18 | 22 | 78 | X | — | — |
14 | Subtle TMA + CNI tox | 14 | 9 | 61 | 39 | — | — | — |
15 | TMA (classical case) | 20 | 3 | 87 | 13 | X | X | — |
16 | TMA (classical case) | 17 | 6 | 74 | 26 | X | — | — |
17 | TMA with rare thrombi | 19 | 4 | 83 | 17 | X | X | — |
18 | TMA with small thrombi | 5 | 18 | 22 | 78 | X | — | — |
19 | No TMA (GN with deposits) | 4 | 19 | 17 | 83 | X | X | — |
20 | TMA (acute and chronic) | 22 | 1 | 96 | 4 | X | X | — |
21 | TMA (acute and chronic) | 21 | 2 | 91 | 9 | X | X | — |
22 | TMA + Nephrosclerosis | 18 | 5 | 78 | 22 | X | — | — |
23 | No TMA (chronic AMR + TG + weak C4d+) | 10 | 13 | 43 | 57 | — | — | — |
24 | No TMA (chronic AMR + TG + weak C4d+) | 6 | 17 | 26 | 74 | X | — | — |
25 | TMA (classical case) | 22 | 1 | 96 | 4 | X | X | — |
26 | TMA (classical case) | 21 | 2 | 91 | 9 | X | — | — |
27 | TMA + Hypertensive arteriopathy | 21 | 2 | 91 | 9 | X | — | — |
28 | TMA (classical case) | 23 | 0 | 100 | 0 | X | X | X |
29 | TCMR | 5 | 18 | 22 | 79 | X | — | — |
30 | TMA (focal) + AMR | 12 | 11 | 52 | 48 | — | — | — |
31 | TMA (classical case) | 21 | 2 | 91 | 9 | X | X | — |
32 | No TMA | 12 | 11 | 52 | 48 | — | — | — |
33 | TMA (classical case) | 23 | 0 | 100 | 0 | X | X | X |
34 | No TMA (rec. MPGN) | 14 | 19 | 42 | 58 | X | — | — |
35 | No TMA (rec. IgA nephropathy) | 2 | 21 | 9 | 91 | X | X | — |
36 | TMA (classical case) | 23 | 0 | 100 | 0 | X | X | X |
37 | TMA + AMR | 21 | 2 | 91 | 9 | X | X | — |